This Company Wants to Cure Pancreatic Cancer Using AI

Four people stand, eyes squinting, on the verdant, freshly mowed field of Boston's Fenway Park. The smiles on their faces are broad, if a bit shy. They are among the lucky ones--the tiny share of people who fought and survived pancreatic cancer. The scene is from a photograph pinned to a cubicle at Beth Israel Deaconess Medical Center in Boston. "What is it about these four people on the field?" asks A. James Moser, co-director of the Pancreas and Liver Institute and director of the Pancreatic Cancer Research Institute at Beth Israel Deaconess Medical Center.